Publication | Open Access

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

Cyclophosphamide PretreatmentBreast OncologyOncologyMedicineImmunologyTumor ImmunityImmune Checkpoint InhibitorBreast CancerActive Specific ImmunotherapyCancer TreatmentImmunotherapyPharmacology